Register Cart 0

Generic placeholder image

Current Pharmacogenomics and Personalized Medicine

Editor-in-Chief

ISSN (Print): 1875-6921
ISSN (Online): 1875-6913

Back Subscribe

Editorial [A Transdisciplinary Forum for Study of Individual and Population Variability in Response to Health Interventions and Personalized Medicine]

Author(s): V. Ozdemir and T. Someya

Volume 7, Issue 3, 2009

Page: [146 - 148] Pages: 3

DOI: 10.2174/1875692110907030146

Open Access Journals Promotions 2

conference banner

Next »

Rights & Permissions Print Cite

Article Metrics

12

Wayfinder Image

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Open Access Journals Promotions

Related Articles

One Special Question to Start with: Can HIF/NFkB be a Target in Inflammation?
Endocrine, Metabolic & Immune Disorders - Drug Targets

Selective Toxicity of Apigenin on Cancerous Hepatocytes by Directly Targeting their Mitochondria
Anti-Cancer Agents in Medicinal Chemistry

Role of Rap2 and its Downstream Effectors in Tumorigenesis
Anti-Cancer Agents in Medicinal Chemistry

Leukocyte P2 Receptors: A Novel Target for Anti-inflammatory and Antitumor Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders

Functional Nanogels for Biomedical Applications
Current Medicinal Chemistry

Potential Roles of Siglecs in the Regulation of Allo-Immune Reaction
Current Protein & Peptide Science

Study on Adsorption and Sustained Release of Eucommia ulmoides Oliv. Leaf Extracts on Activated Carbon
Current Drug Delivery

The Leech: A Novel Invertebrate Model for Studying Muscle Regeneration and Diseases
Current Pharmaceutical Design

Preparation and Characterization of MKT-077 Nanoparticles for Treatment of Alzheimer’s Disease and Other Tauopathies
Pharmaceutical Nanotechnology

Oncogene-Blocking Therapies: New Insights from Conditional Mouse Tumor Models
Current Cancer Drug Targets

Cetuximab Inhibits Gastric Cancer Growth in vivo, Independent of KRAS Status
Current Cancer Drug Targets

Understanding the Role of Aldose Reductase in Ocular Inflammation
Current Molecular Medicine

Surface Antigens/Receptors for Targeted Cancer Treatment: The GnRH Receptor / Binding Site for Targeted Adenocarcinoma Therapy
Current Cancer Drug Targets

The Effect of Melatonin on Superoxide Dismutase and Glutathione Peroxidase Activity, and Malondialdehyde Levels in the Targeted and the Non-targeted Lung and Heart Tissues after Irradiation in Xenograft Mice Colon Cancer
Current Molecular Pharmacology

The Role of CD40 Expression in Dendritic Cells in Cancer Biology; A Systematic Review
Current Cancer Drug Targets

Angiotensin-(1-7): A Peptide Hormone with Anti-Cancer Activity
Current Medicinal Chemistry

Perspectives in Tissue Microarrays
Combinatorial Chemistry & High Throughput Screening

Comparative Analysis of Current Modality of Therapy in Head and Neck Squamous Cell Carcinoma Correlating the Expression Level of p38α
Current Cancer Therapy Reviews

Osteoinductive Small Molecules: Growth Factor Alternatives for Bone Tissue Engineering
Current Pharmaceutical Design

Advances in Tumor Targeted Liposomes
Current Molecular Medicine

© 2024 Bentham Science Publishers | Privacy Policy